Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma

NCT00002226 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Sarcoma, Kaposi
HIV Infections

Interventions

DRUG: SU5416

Sponsor

SUGEN